Related Experiment Video
Updated: May 5, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Midterm Outcomes: A Comprehensive Approach to Surgery for Hypertrophic Obstructive Cardiomyopathy
Lye-Yeng Wong1, Ruben Vila2, Gurion Lantz2
1Division of Cardiothoracic Surgery, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, California.
Insights
A comprehensive surgical approach for obstructive hypertrophic cardiomyopathy (HCM) significantly improves left ventricular outflow tract (LVOT) obstruction and mitral regurgitation, leading to excellent patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Hypertrophic Cardiomyopathy Research
Background:
- Obstructive hypertrophic cardiomyopathy (HCM) involves complex left ventricular outflow tract (LVOT) abnormalities.
- Surgical intervention aims to correct these multifaceted issues.
Purpose of the Study:
- To evaluate the midterm outcomes of a comprehensive surgical strategy for LVOT obstruction in HCM.
- To assess the effectiveness of addressing associated mitral valve and myocardial abnormalities.
Main Methods:
- Single-institution retrospective study of 103 HCM patients undergoing septal myectomy (2016-2023).
- Tracking of New York Heart Association (NYHA) functional class, LVOT gradient, and mitral valve function pre- and post-procedure.
- Surgical techniques included septal myectomy, mitral valve repair/resection, and myocardial band resection.
Main Results:
- Preoperative LVOT gradient averaged 36.4 mm Hg, with 50.5% experiencing moderate/severe mitral regurgitation.
- Post-surgery, 91% of patients achieved NYHA functional class I or II.
- Mean LVOT gradient decreased to 11 mm Hg, and only 1 patient had >mild mitral regurgitation post-operatively.
Conclusions:
- A comprehensive surgical approach addressing all HCM-related abnormalities yields outstanding midterm results.
- This strategy effectively resolves LVOT obstruction and improves mitral valve function.
- Surgical correction offers significant functional improvement for patients with obstructive HCM.
Background:
Left ventricular outflow tract (LVOT) obstruction in obstructive hypertrophic cardiomyopathy (HCM) is caused by a constellation of abnormalities. This study reviewed outcomes of a comprehensive approach to correct these abnormalities during surgery.
Methods:
This was a single-institution study of patients with HCM who underwent septal myectomy from 2016 to 2023. Their New York Heart Association functional classification and most recent echocardiogram that estimated LVOT gradient and mitral valve function were tracked.
Results:
The study included 103 patients with a mean age of 54 years (interquartile range, 40-67 years) and common comorbidities: hypertension (50%) and atrial fibrillation (25%). On average, the preprocedure resting echocardiogram showed an LVOT gradient of 36.4 mm Hg and moderate or severe mitral regurgitation in 50.5% of patients. All patients underwent septal myectomy, and associated abnormalities contributing to LVOT obstruction were addressed. Elongation of the anterior leaflet of the mitral valve was typically treated with papillary muscle realignment (72%). Aberrant papillary muscle heads and elongated secondary chordae tendineae contributing to systolic anterior motion were resected (66%). Myocardial bands, including apicoseptal bands contributing to LVOT obstruction, were resected (68%). With an average follow-up of 4 years, 91% of patients were considered to be in New York Heart Association functional class I or II. Long-term echocardiographic follow-up showed a mean peak LVOT gradient of 11 mm Hg (interquartile range, 4-13 mm Hg). Only 1 patient had more than mild mitral regurgitation.
Conclusions:
A comprehensive surgical approach to HCM that addresses the entire constellation of abnormalities associated with HCM, including mitral valve anterior leaflet elongation, aberrant or displaced mitral valve subvalvular apparatus, and myocardial bands, leads to outstanding midterm outcomes.
More Related Videos
07:02Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
09:24O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management